Valion Bio (TIVC) Depreciation and Depletion (2021 - 2025)
Valion Bio has reported Depreciation and Depletion over the past 5 years, most recently at $3000.0 for Q4 2025.
- For Q4 2025, Depreciation and Depletion changed N/A year-over-year to $3000.0; the TTM value through Dec 2025 reached $5000.0, up 66.67%, while the annual FY2025 figure was $5000.0, 66.67% up from the prior year.
- Depreciation and Depletion for Q4 2025 was $3000.0 at Valion Bio, up from $1000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $4000.0 in Q2 2023 and troughed at $1000.0 in Q1 2024.
- A 5-year average of $2000.0 and a median of $2000.0 in 2021 define the central range for Depreciation and Depletion.
- Biggest five-year swings in Depreciation and Depletion: surged 100.0% in 2023 and later plummeted 75.0% in 2024.
- Year by year, Depreciation and Depletion stood at $2000.0 in 2021, then skyrocketed by 50.0% to $3000.0 in 2022, then crashed by 33.33% to $2000.0 in 2023, then plummeted by 50.0% to $1000.0 in 2024, then surged by 200.0% to $3000.0 in 2025.
- Business Quant data shows Depreciation and Depletion for TIVC at $3000.0 in Q4 2025, $1000.0 in Q2 2025, and $1000.0 in Q1 2025.